Small-molecule inhibitor targeting the Hsp90-Cdc37 protein-protein interaction in colorectal cancer
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Directly disrupting the Hsp90-Cdc37 complex can selectively down-regulate kinase clients of Hsp90 and achieve cell cycle arrest.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For instance, the heat shock protein (Hsp90)-Cdc37 PPI promotes colorectal cancer.”
From The design and development of covalent protein-protein interaction inhibitors for cancer treatment (2020) · cites this paper as [104]
In the citing paper
“PPI inhibitors of Hsp90-Cdc37 could achieve selective inhibition of Hsp90 kinase without affecting other interactions that could lead to unnecessary toxicity [104].”
From The design and development of covalent protein-protein interaction inhibitors for cancer treatment (2020) · cites this paper as [104]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Kollman, P. A., Massova, I., Reyes, C., Kuhn, B., Huo, S., Chong, L., Lee, M., Lee, T., Duan, Y., Wang, W., et al. (2000) · Accounts of Chemical Research · doi:10.1021/ar000033j · Cited by 4,978
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261
Targeting the dynamic HSP90 complex in cancer
Trepel, J., Mollapour, M., Giaccone, G., & Neckers, L. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2887 · Cited by 1,514
Gohlke, H., Kiel, C., & Case, D. A. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00610-7 · Cited by 1,192 · cited 1×
“(35, 36), which might provide critical insights into hotspots.”
BackgroundHsp90 Molecular Chaperone Inhibitors: Are We There Yet?
Neckers, L., & Workman, P. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1000 · Cited by 891
Quantitative Analysis of Hsp90-Client Interactions Reveals Principles of Substrate Recognition
Taipale, M., Krykbaeva, I., Koeva, M., Kayatekin, C., Westover, K. D., Karras, G. I., & Lindquist, S. (2012) · Cell · doi:10.1016/j.cell.2012.06.047 · Cited by 879 · cited 1×
“Quantitative analysis of Hsp90-cochaperone interactions has been reported to reveal specificity in substrate recognition (6).”
BackgroundConverging free energy estimates: MM‐PB(GB)SA studies on the protein–protein complex Ras–Raf
Gohlke, H., & Case, D. A. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.10379 · Cited by 860 · cited 1×
“(35, 36), which might provide critical insights into hotspots.”
BackgroundCheatham, T. E. I., Miller, J. L., Fox, T., Darden, T. A., & Kollman, P. A. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00119a045 · Cited by 859 · cited 1×
“In the whole simulation process, the particle mesh Ewald method was used to calculate long-range electrostatic interactions (33).”
MethodAll-Atom Structure Prediction and Folding Simulations of a Stable Protein
Simmerling, C., Strockbine, B., & Roitberg, A. E. (2002) · Journal of the American Chemical Society · doi:10.1021/ja0273851 · Cited by 589
Cited by
Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions
Li, L., Wang, L., You, Q.-D., & Xu, X.-L. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00940 · Cited by 202
Self-citationRational Design of Peptide-Based Inhibitors Disrupting Protein-Protein Interactions
Wang, X., Ni, D., Liu, Y., & Lu, S. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.682675 · Cited by 150
“Without doubt, it is an ever challenging task to design small molecules possessing rigid and hydrophobic features by downsizing the molecular size and mimicking key residues of original peptides (Wang et al., 2019).”
BackgroundPAAN/MIF nuclease inhibition prevents neurodegeneration in Parkinson’s disease
Park, H., Kam, T., Peng, H., Chou, S.-C., Mehrabani-Tabari, A. A., Song, J., Yin, X., Karuppagounder, S. S., Umanah, G. K. E., Rao, A., et al. (2022) · Cell · doi:10.1016/j.cell.2022.04.020 · Cited by 134
Heat shock protein 90: biological functions, diseases, and therapeutic targets
Wei, H., Zhang, Y., Jia, Y., Chen, X., Niu, T., Chatterjee, A., He, P., & Hou, G. (2024) · MedComm · doi:10.1002/mco2.470 · Cited by 131
“159 Furthermore, Chen et al. 273 conducted a study on another inhibitor known as DCZ3112, which also targets the HSP90–CDC37 PPI.”
BackgroundZuo, W., Pang, Q., Zhu, X., Yang, Q., Zhao, Q., He, G., Han, B., & Huang, W. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01601-1 · Cited by 113
Metadata
- Authors
- Wang, L., Zhang, L., Li, L., Jiang, J., Zheng, Z., Shang, J., Wang, C., Chen, W., Bao, Q., Xu, X., Jiang, Z., Zhang, J., & You, Q.
- Affiliations
- China Pharmaceutical University (CN)
- Shanghai Jiao Tong University (CN)
- Corresponding author
- Jiang, Zhengyu
- Zhang, Jian
- You, Qidong
- ORCID
- Venue
- Science Advances
- Published
- 2019-09-06
- Volume
- 5
- Issue
- 9
- Pages
- eaax2277-eaax2277
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC6750927
- OpenAlex
- W2974325953
- Cited by
- 110
- References
- 39
- Citations by year
- 2026: 11 · 2025: 23 · 2024: 18 · 2023: 10 · 2022: 17 · 2021: 16 · 2020: 14 · 2019: 1
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81573346, 81773639, 81773581, 81602948)
- China Postdoctoral Science Foundation (2018M642376)
- Double First Class Innovation Team of China Pharmaceutical University (CPU2018GY02)
- Natural Science Foundation of Jiangsu Province of China (BK2016746)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- protein-protein interaction, small molecule inhibitors, colorectal cancer, CDK4, cell cycle arrest, HCT116 cells, Hsp90 chaperone, cancer therapy
- MeSH terms
- A549 Cells, PC-3 Cells, Animals, Antineoplastic Agents, Humans, Mice, Inbred BALB C, Mice, Nude, Neoplasm Proteins, Colorectal Neoplasms, Cell Cycle Proteins, Chaperonins, HSP90 Heat-Shock Proteins, HT29 Cells, Xenograft Model Antitumor Assays, HCT116 Cells, Mice, Hep G2 Cells, MCF-7 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Small-molecule inhibitor targeting the Hsp90-Cdc37 protein-protein interaction in colorectal cancer. https://app.cochat.ai/papers/10.1126/sciadv.aax2277
- The paper
- Wang, L., Zhang, L., Li, L., Jiang, J., Zheng, Z., Shang, J., Wang, C., Chen, W., Bao, Q., Xu, X., Jiang, Z., Zhang, J., & You, Q. (2019). Small-molecule inhibitor targeting the Hsp90-Cdc37 protein-protein interaction in colorectal cancer. Science Advances. https://doi.org/10.1126/sciadv.aax2277
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.